Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis

Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis

Saved in:

Bibliographic Details
Main Authors:	Rocio Asensi-Diez, David Furones Araujo, Carmen Gallego Fernández
Format:	Article
Language:	English
Published:	Elsevier 2017-05-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/10760.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
by: Ahmed Musa, et al.
Published: (2012-01-01)

Epidemiology of visceral leishmaniasis in Georgia.
by: Giorgi Babuadze, et al.
Published: (2014-03-01)

Visceral leishmaniasis: Recent updates
by: Jaya Chakravarty, et al.
Published: (2025-06-01)

Health economic evaluations of visceral leishmaniasis treatments: a systematic review.
by: Daniel S Marinho, et al.
Published: (2015-02-01)

Clinical and epidemiological aspects of visceral leishmaniasis in children
by: Lívia Moreira Barros, et al.
Published: (2014-06-01)

Clinical and epidemiological aspects of visceral leishmaniasis in children
by: Lívia Moreira Barros, et al.
Published: (2014-06-01)

Clinical and epidemiological aspects of visceral leishmaniasis in children
by: Lívia Moreira Barros, et al.
Published: (2014-06-01)

Clinical and epidemiological aspects of visceral leishmaniasis in children
by: Lívia Moreira Barros, et al.
Published: (2014-06-01)

SPECIALIZED NURSING TERMINOLOGY FOR PEOPLE WITH VISCERAL LEISHMANIASIS
by: Diego Dias de Araújo, et al.
Published: (2023-04-01)

Detection of IL-27 in Patients with Visceral leishmaniasis
by: Suha Abdullah Oudah ALfakar, et al.
Published: (2025-06-01)

Shigella Bacteremia in a Patient with Visceral Leishmaniasis
by: Mengistu Endris, et al.
Published: (2013-01-01)

Pediatric visceral leishmaniasis: diagnosis and therapy
by: O. V. Samodova, et al.
Published: (2021-03-01)

Sexual and vertical transmission of visceral leishmaniasis
by: Andreia P Turchetti, et al.
Published: (2014-04-01)

Determinants for the development of visceral leishmaniasis disease.
by: Laura-Isobel McCall, et al.
Published: (2013-01-01)

Development of Vaccines against Visceral Leishmaniasis
by: Krystal J. Evans, et al.
Published: (2012-01-01)

Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma
by: Zhong Min, et al.
Published: (2024-12-01)

Community-based active case detection of hidden visceral leishmaniasis and post-kala-azar dermal leishmaniasis cases to support the elimination of visceral leishmaniasis in Bihar, India
by: Kuldeep Singh Deepak, et al.
Published: (2025-04-01)

LEVELS OF SERUM IMMUNOGLOBULINS AND COMPLEMENTS IN PATIENTS WITH VISCERAL LEISHMANIASIS
by: Wafaa Sadoon Shani
Published: (2006-12-01)

Visceral Leishmaniasis with Endobronchial Involvement in an Immunocompetent Adult
by: Konstantinos Kotsifas, et al.
Published: (2011-01-01)

Visceral leishmaniasis and HIV coinfection in Latin America.
by: José Angelo Lindoso, et al.
Published: (2014-09-01)

Screening for visceral leishmaniasis in humans and animals in Laos
by: Tamalee Roberts, et al.
Published: (2025-08-01)

Modeling and analyzing the transmission dynamics of visceral leishmaniasis
by: Lan Zou, et al.
Published: (2017-09-01)

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
by: Om Prakash Singh, et al.
Published: (2015-01-01)

Chronic Visceral Leishmaniasis in a Nonendemic Region
by: Sudha Sharma, et al.
Published: (2024-12-01)

Viscereal leishmaniasis: Pathogenetic basis of clinic variety
by: Đokić Milomir
Published: (2003-01-01)

The development and maintenance of immunity against visceral leishmaniasis
by: Rahul Tiwari, et al.
Published: (2024-12-01)

Factors associated with visceral leishmaniasis in the americas: a systematic review and meta-analysis.
by: Vinícius Silva Belo, et al.
Published: (2013-01-01)

Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B
by: Betül Tavil, et al.
Published: (2008-02-01)

Spatiotemporal analysis of environmental factors associated with visceral leishmaniasis in northeastern Brazil, 2007–2022
by: Quezia Machado dos Santos Araújo, et al.
Published: (2025-07-01)

Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia.
by: Workagegnehu Hailu, et al.
Published: (2021-01-01)

American Visceral Leishmaniasis: Factors Associated with Lethality in the State of São Paulo, Brazil
by: Geraldine Madalosso, et al.
Published: (2012-01-01)

Epidemiological characteristics and factors associated with Visceral Leishmaniasis in Marsabit County, Northern Kenya
by: Diba Dulacha, et al.
Published: (2019-04-01)

Visceral Leishmaniasis During Pregnancy: A Case Report
by: Spinello Antinori, et al.
Published: (2024-04-01)

Visceral leishmaniasis and lymphoma: a rare and dangerous couple
by: Nicola Battino, et al.
Published: (2025-03-01)

Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
by: Mohammadali Davarpanah, et al.
Published: (2015-01-01)

Infection-adapted emergency hematopoiesis promotes visceral leishmaniasis.
by: Belma Melda Abidin, et al.
Published: (2017-08-01)

A case of visceral leishmaniasis imported from Armenia
by: A. L. Rossina, et al.
Published: (2023-10-01)

Global Distribution and Prediction of Transmission-Risk of Visceral Leishmaniasis
by: Xubin Wu, et al.
Published: (2024-03-01)

Clinical features and treatment outcomes of visceral leishmaniasis patients admitted to three centers in Oromia, Ethiopia
by: Samson Tekalign, et al.
Published: (2020-06-01)

Treatment failure of pentavalent antimonial therapy for human visceral leishmaniasis: a meta-analysis
by: Caitlin M Jones, et al.
Published: (2019-12-01)